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Abstract: Previous work in intact awake and sleeping goats has found that 
unilateral blockade of excitatory inputs in the ventral respiratory column 
(VRC) elicits changes in the concentrations of multiple neurochemicals, 
including serotonin (5-HT), substance P, glycine, and GABA, while increasing 
or having no effect on breathing. These findings are consistent with the 
concept of interdependence between neuromodulators, whereby attenuation 
of one modulator elicits compensatory changes in other modulators to 
maintain breathing. Because there is a large degree of redundancy and 
multiplicity of excitatory inputs to the VRC, we herein tested the hypothesis 
that combined unilateral blockade of muscarinic acetylcholine (mACh), 
neurokinin-1 (NK1, the receptor for substance P), and 5-HT2A receptors would 
elicit changes in multiple neurochemicals, but would not change breathing. 
We unilaterally reverse-dialyzed a cocktail of antagonists targeting these 
receptors into the VRC of intact adult goats. Breathing was continuously 
monitored while effluent fluid from dialysis was collected for quantification of 
neurochemicals. We found that neither double blockade of mACh and NK1 
receptors, nor triple blockade of mACh, NK1, and 5-HT2A receptors 
significantly affected breathing (P ≥ 0.05) in goats that were awake or in non-
rapid eye movement (NREM) sleep. However, both double and triple blockade 
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increased the effluent concentration of substance P (P < 0.001) and 
decreased GABA concentrations. These findings support our hypothesis and, 
together with past data, suggest that both in wakefulness and NREM sleep, 
multiple neuromodulator systems collaborate to stabilize breathing when a 
deficit in one or multiple excitatory neuromodulators exists. 
Keywords: neuromodulation, muscarinic receptor, neurokinin-1 receptor, 5-
HT2A receptor 
The control of breathing is dependent upon the balance of 
excitatory and inhibitory neuromodulators acting on their respective 
receptors at multiple sites in the brainstem.10,40 Currently, the 
mechanisms underlying the orchestrated release of multiple 
neuromodulators, and whether or how each modulator can affect the 
release of other neurochemicals, are not fully understood. These topics 
continue to be of fundamental biological and clinical interest. 
Acetylcholine (ACh), substance P (SP), and serotonin (5-HT) are 
neurochemicals previously shown to have excitatory effects on the 
central control of breathing in multiple models utilizing reduced 
preparations and whole animals.3,5,11,16,17,28,32,34,35,42,46 For example, in 
brainstem slices containing the pre-Bötzinger Complex (preBötC), a 
site critical for the generation of inspiratory rhythm,36 application of 
exogenous ACh or the cholinergic agonists carbachol and muscarine 
depolarizes inspiratory neurons, induces a long-lasting inward current, 
and increases respiratory frequency.34 These effects were blocked by 
atropine (ATR), a nonselective muscarinic ACh (mACh) receptor 
antagonist.34 Likewise, the importance of SP neuromodulation has 
been demonstrated in rats and goats, wherein neurons expressing the 
neurokinin-1 receptor (an SP receptor) were selectively 
destroyed,16,28,46 resulting in abnormal breathing patterns and a 
reduced ventilatory CO2 chemoreflex. Additionally, work in slice 
preparations has shown that co-localized 5-HT and SP, presumably 
from the raphé nucleus, provide tonic excitation to preBötC neurons 
via 5-HT2 receptors and NK1 receptors, respectively.11,32 In agreement 
with this evidence, elimination of central serotonergic neurons (and 
thus all co-expressed neuropeptides) results in severe apnea, 
hypoventilation, and high mortality rates in transgenic neonatal 
mice,17 presumably in part through reduced neuromodulation in the 
respiratory network. 
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Despite a large body of work demonstrating the importance of 
ACh, 5-HT, and SP as sources of excitation for respiratory output, 
studies in our laboratory on intact goats while they were awake and 
during sleep have found that unilateral dialysis of antagonists of mACh 
receptors or NK1 receptors in the ventral respiratory column (VRC) 
either increase or do not change breathing.25–27 However, in these 
studies, we found that receptor antagonism alters the concentration of 
one or more neuromodulators in the effluent mock cerebrospinal fluid 
(mCSF). Compensation can be defined as a means of counteracting 
variation or neutralizing the effect of variations. Thus we hypothesize 
that these alterations in neurochemical levels likely compensated for 
the disruption in excitatory transmission in the VRC during receptor 
blockade, thereby preventing a decrease in breathing. These data 
support the concept of interdependence among neuromodulators, 
whereby attenuation of one source of excitation may be compensated 
for by other modulator systems to preserve a normal level of 
breathing. Therefore, in awake and sleep states, breathing may 
decrease only with attenuation of multiple (rather than individual) 
receptor types. 
Herein, we first sought to determine the effects on breathing 
and effluent neurochemical concentrations of blockade of 5-HT2A 
receptors with the highly selective antagonist MDL 11939 (MDL) in the 
VRC of adult goats. On the basis of previous findings with unilateral 
dialysis of mACh receptor and NK1 receptor antagonists,25–27 we 
believed that a logical next step would be to further explore the 
concept of neuromodulator interdependence by testing the hypothesis 
that unilateral double blockade of mACh and NK1 receptors, or triple 
blockade of receptors of mACh, NK1, and 5-HT2A would not alter 
breathing, but would elicit compensatory changes in multiple 
neurochemicals. We also tested the hypothesis that there would be 
sleep state-dependent effects on breathing of dialysis of a triple 
cocktail of antagonists; thus these studies were also conducted at 
night while goats were awake and during natural non-rapid eye 
movement (NREM) sleep. 
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Materials And Methods 
Goats.  
All animals studied herein (n = 13) were adult, nonpregnant, 
female goats with an average weight of 43.1 ± 2.5 kg. Animals were 
housed and studied in an environmental chamber with a 12:12-h light-
dark cycle (lights-on at 6:00 A.M.). Goats were permitted ad libitum 
access to food and water, except during a 24-h fasting period 
immediately before all surgeries. Animals were acclimated to the 
environment for ≥3 days before any procedures were initiated. All 
aspects of the studies reported herein were reviewed and approved by 
the Medical College of Wisconsin's Institutional Animal Care and Use 
Committee before commencing any procedures or protocols. 
Surgical procedures.  
Before all surgeries, goats were anesthetized with ketamine (5.0 
ml, 100 mg/ml, iv), intubated, and mechanically ventilated (2% 
isoflurane in a background of 100% oxygen). Flunixin meglumine (1 
mg/kg, im), a nonsteroidal anti-inflammatory analgesic, was given 
once perioperatively. Throughout each surgery and immediately 
thereafter, rectal body temperature (Tr), heart rate, blood oxygen 
saturation, and respiratory rate were recorded at regular intervals. 
Ceftiofur sodium (4 mg/kg, im) was administered daily and all surgical 
sites were treated daily with triple antibiotic for ≥7 days after surgery. 
Buprenorphine hydrochloride (0.005 mg/kg, im) was given twice daily 
for 2 days postoperatively to alleviate pain. All surgeries were 
performed under sterile conditions. 
Electroencephalographic (EEG) and electrooculographic (EOG) 
electrodes were implanted in the midline cranium and superior orbital 
ridge, respectively, for monitoring and scoring sleep state. Goats were 
allowed to recover for ≥14 days after instrumentation with EEG and 
EOG electrodes before undergoing craniotomy, in which stainless steel 
microtubules (MTs, 70.0 mm length, 1.27 mm OD, 0.84 mm ID) were 
chronically implanted (unilaterally or bilaterally) into medullary tissue 
targeting the preBötC. During these procedures, after an occipital 
craniotomy was created, the dura mater was excised, and the 
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posterior cerebellum and dorsal medulla were exposed to visualize 
obex, which served as a physical landmark for implantation of MTs. As 
determined in previous studies,20,47 the goat preBötC is approximately 
2.5–3.5 mm rostral from obex, 4.0–5.0 mm lateral to midline, and 
4.0–6.0 mm from the dorsal surface of the medulla (ventral to nucleus 
ambiguus). To avoid rupturing blood vessels on the medullary surface, 
the actual site of implantation in some goats was adjusted. MTs were 
permanently secured with dental acrylic. Stylets of the same length as 
the MTs were inserted into the MTs such that they did not protrude 
into or disrupt medullary tissue. The skin was then sutured closed and 
treated with triple antibiotic. 
Physiological variables.  
Animals were trained to become accustomed to all equipment 
and study protocols. To measure respiratory parameters, a custom-
made plastic mask with a one-way breathing valve was secured to the 
goat's snout. Inspiratory and expiratory tubing were attached to either 
side of the valve. A pneumotachograph, attached in series to the 
inspiratory side of the breathing valve, was used to measure 
inspiratory flow (or minute ventilation, VI, liters/min), breathing 
frequency (breaths/min), and tidal volume (VT, liters/breath). 
Ventilatory parameters were continuously recorded on a Windaq data 
acquisition system for later offline analysis. For accurate calculation of 
ventilation and for assurance that the goats were in good health, a 
thermocouple was inserted into the rectum to record Tr at regular 
intervals throughout all studies. Tr remained within normal range 
(38.5–39.9°C) for the vast majority of studies. For night studies, data 
were collected in an identical manner, except EEG and EOG cables 
were connected to the animal's head to monitor sleep state. 
In vivo dialysis.  
A dialysis probe (70.0 mm shaft, 2.0 mm membrane, 0.5 mm 
membrane diameter, 20 kDa cutoff, 3 μl internal volume; Harvard 
Apparatus, Holliston, MA) was inserted unilaterally into one MT. The 
dimensions of the probe allowed only the membrane tip to penetrate 
the tissue. The vehicle solution for all studies was mCSF (in mM: 124 
NaCl, 2.0 KCl, 2.0 MgCl2, 1.3 K2PO4, 2.0 CaCl2, 11 glucose, and 26 
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NaHCO3−, pH 7.32, in sterile distilled water) alone or with 1.25% 
DMSO (vol/vol), as appropriate. All antagonists were dissolved in 
mCSF or mCSF with DMSO. Solutions were warmed in a tonometer to 
39°C and equilibrated with 6.4% carbon dioxide and 21% oxygen 
(nitrogen-balanced) before being loaded into a syringe and attached to 
a syringe pump (Harvard Apparatus). The syringe was connected to 
the probe via polypropylene tubing. Solutions were delivered at a rate 
of 25 μl/min. The length of the polypropylene tubing (150 or 180 cm) 
resulted in an approximate delay of 20 min between initiation of 
dialysis and when the solution in the syringe reached the probe. 
Each dialysis study proceeded in the following order: a dialysis 
probe was inserted unilaterally into one MT and the animal was given 
30 min to stabilize; predialysis data were collected for 30 min; mCSF 
was dialyzed for 60 min (hour 1); antagonist solution was dialyzed for 
60 min (hour 2); and mCSF was dialyzed for 60 min (hour 3). In time-
control studies, mCSF was dialyzed during hour 2. The dialysate 
(effluent flow from the probe after solute exchange at the probe tip) 
was collected at the end of each hour of dialysis in modified cryotubes, 
aliquoted, and then frozen at −80°C for later analysis of 
neurochemical content. 
The following antagonists were used: ATR (Sigma-Aldrich, St. 
Louis, MO), a nonselective mACh receptor antagonist; Spantide I (SPA, 
U.S. Biological), an NK1 receptor antagonist; and MDL (Santa Cruz 
Biotechnology, Santa Cruz, CA), a 5-HT2 receptor antagonist with 
greater selectivity for the 5-HT2A receptor over the 5-HT2C receptor. 
The following groups of animals were studied (goat numbers listed 
according to the inset table in Fig. 1), differing only in the solution 
dialyzed during hour 2 and day/night condition: Group 1, day 0.5 mM 
MDL in 1.25% DMSO (n = 6, goats 1, 2, 3, 7, 8, and 10); Group 2, 
day double cocktail (5 mM ATR and 267 μM SPA, n = 5, goats 1 and 
7–10); Group 3, day triple cocktail (5 mM ATR, 500 μM SPA, and 0.5 
mM MDL in 1.25% DMSO, n = 6, goats 2–6 and 11); and Group 4, 
night triple cocktail (5 mM ATR, 500 μM SPA, and 0.5 mM MDL in 
1.25% DMSO, n = 6, goats 2–6 and 11). Goats 12 and 13 were 
studied, but their data were not included in group means or statistical 
analyses. In general, daytime dialysis studies were completed between 
9:00 A.M. and 2:00 P.M., whereas night studies were completed 
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between 8:00 P.M. and 2:00 A.M. For any individual animal, ≥36 h 
separated all studies. 
 
Fig. 1. Microtubule (MT) placement (dialysis site) of each goat studied, excluding 
goats in time-control studies. Sections are taken from the goat brainstem atlas (7) 
and, for simplicity, MT placements are illustrated on three representative sections 
only. Red circle indicates approximate location of the goat pre-Bötzinger Complex 
(preBötC). Distance rostral from obex is indicated above each section. Circled numbers 
represent each goat studied and the left/right placement of the MTs in which studies 
were carried out. The corresponding N-methyl-d-aspartic acid (NMDA) injection (100 
mM, 500 nl) response for each dialysis site, expressed as a percent of control, is also 
indicated (inset table, blank entries indicate sides not included in analysis). Gray 
shading (inset table) indicates animals anecdotally mentioned in the discussion but 
excluded from group means and statistical analyses. Tissue from goat 11 was not 
usable for Nissl staining and is not represented on the sections. 
Mock CSF and N-methyl-d-aspartic acid injections.  
Because application of glutamate receptor agonists to the 
preBötC elicits a tachypneic ventilatory response,20,24,37,47 functional 
assays utilizing injections of mCSF and a glutamate receptor agonist 
into the MTs were performed to approximate MT placement relative to 
the preBötC. The injection tube was inserted only up to the distal end 
of the MT to avoid tissue damage. In these injection studies, breathing 
was measured as described above. After collection of control data (30 
min), mCSF or N-methyl-d-aspartic acid (NMDA, 100 mM) was 
unilaterally injected (500 nl) into an MT. Injections were repeated on 
the contralateral MT after breathing returned to baseline levels. 
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Neurochemical analysis.  
Neurochemical analyses were performed by a core assay 
laboratory using methods identical to those used by Muere et al.25 
These protocols are thus quoted from Muere et al.:25 “Glycine 
[glutamine, (GLN)] and γ-aminobutyric acid (GABA) were measured by 
reverse-phase high-performance liquid chromatography with 
fluorescent detection using the following parameters: Waters Resolve 
C18 column (150 × 3.9), a fluorescent detector with excitation at 229 
nm and emission at 470 nm, β-alanine internal standard, and o-
phthaldialdehyde derivitization. For detection and measurement of 5-
HT, electrochemical detection with the same type of column was used, 
but with a potential setting of 0.6 volts vs. Ag/AgCl reference electrode 
and a N-methylserotonin internal standard. . . . A commercially 
available immunoassay (Assay Designs 900-018, range 9.76–10,000 
pg/ml) was used to measure SP via a microplate reader at 405 nm.” 
Data analysis.  
Inspiratory flow was calibrated at the end of all experiments and 
data were analyzed as per past studies.25–27 Breath-by-breath analysis 
of ventilatory data was carried out using custom-made programs. For 
night studies, EEG and EOG activity was used to visually score each 
breath according to the awake, rapid-eye-movement (REM), or NREM 
sleep states. Scoring was performed by the same investigator for all 
studies. Although REM was frequently observed, there were not 
enough data for ventilatory analysis during the REM state. 
As in past reports,26,27 we compared data from this investigation 
to established time-control studies25 in which mCSF was dialyzed in all 
3 h. The present studies were carried out under the same conditions 
using identical methodologies as those in time-control studies. 
Accordingly, we utilized these control data for two important reasons: 
1) to minimize the number of goats used because repeating control 
experiments may violate policies regarding using the smallest number 
of animals to address scientific questions; and 2) we believe that direct 
comparisons between time-control data and data from the studies 
herein are necessary for interpretation and for framing results in 
context with previous findings. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Applied Physiology, Vol 119, No. 3 (August 1, 2015): pg. 308-320. DOI. This article is © American Physiological 
Society and permission has been granted for this version to appear in e-Publications@Marquette. American Physiological 
Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from American Physiological Society. 
10 
 
All ventilatory data were binned in 15-min bins. Two-way 
repeated-measures (RM) ANOVAs (one-factor repetition, group and 
time/bin as factors, Holm-Sidak test post hoc when appropriate) were 
performed for each ventilatory parameter. We thus used the P value of 
the interaction term from the results of two-way RM ANOVAs to 
determine whether the effect on breathing over time of antagonist 
dialysis was significantly different from that of time-control studies. 
When the P value of the interaction term was significant, we report 
results of the post hoc test. To minimize noise, we limited the period of 
analysis to the last nine bins of the study [i.e., the last 15-min bin in 
hour 1 (bin 1), the four bins in hour 2 (bins 2–5), and the four bins in 
hour 3 (bins 6–9)]. For night studies, two-way RM ANOVAs (two-factor 
repetition, state and time/bin as factors, Holm-Sidak post hoc test 
when appropriate) were also performed to determine whether there 
were state-dependent effects of antagonist dialysis on breathing. One 
animal did not have sufficient NREM sleep in hour 3 and was excluded 
from analysis by the statistical software; thus for ventilatory variables, 
the sample size for night studies was five. 
As with the ventilatory data, for each group, two-way RM 
ANOVAs (one-factor repetition, group and hour as factors, Holm-Sidak 
test post hoc when appropriate) were performed for each 
neurochemical. We used the P value of the interaction term from the 
results of two-way RM ANOVAs to determine whether the effect on 
effluent neurochemical concentration over time of antagonist dialysis 
was significantly different from that of time-control studies. For night 
triple-cocktail studies, one-way RM ANOVAs (Holm-Sidak test post hoc 
when appropriate) were performed because time-control studies were 
not conducted at night. When the P value of the interaction term or 
one-way RM ANOVA was significant, we report results of the post hoc 
test. 
For any animal, data from replicate studies were averaged 
before inclusion in group comparisons. All statistical analyses were 
performed using SigmaPlot (version 12.0 or 12.5) and all results are 
presented as means ± SE; values of P < 0.05 were considered 
statistically significant. 
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Histological analysis.  
To determine MT placement, animals were sedated with 
ketamine (2.3 ml, 100 mg/ml, iv), cerebral circulation was isolated, 
and the goat was killed via injection of 10.0 ml (iv) of B-euthanasia. 
The cranial vasculature was perfused with PBS via a catheter placed in 
a carotid artery, followed by perfusion with 4% paraformaldehyde in 
PBS. The brainstem was harvested and processed for sectioning and 
Nissl-staining. Nissl-stained images were captured (scanned at 4,000 
dots per inch; Nikon Super Coolscan 9000) and MT placements were 
approximated using Metamorph software. Because the MT was 
inserted from the dorsal surface, the distal extent of the MT tract from 
the dorsal surface was considered to be the dorsal coordinate of MT 
placement; the center of this tract was considered to be the medial-
lateral coordinate. The rostral-caudal coordinate relative to obex was 
determined according to the tissue section on which the distal tip of 
the MT tract was identified. 
Results 
Histological assessment and NMDA injection responses.  
The preBötC in the goat is approximately 2.5–3.5 mm rostral 
from obex, 4.0–5.0 mm lateral from the midline, and 4.0–6.0 mm 
from the dorsal surface of the medulla, ventral to nucleus 
ambiguous.20,47 Figure 1 is a simplified illustration of the MT 
placements of the goats studied herein (excluding those in time-
control studies) and their respective responses to NMDA injections 
(100 mM, 500 nl, Fig. 1 inset table), which has previously been used 
as a physiological marker of the preBötC.26,27 Goats 12 and 13 (gray 
shading, Fig. 1 inset table) are discussed here as examples of animals 
with unusual respiratory responses to cocktail dialysis (see Fig. 10 and 
discussion) but their data were excluded from group means and 
statistical analyses. In all of our microdialysis studies, there has been 
variation in MT placement and the corresponding NMDA responses.26,27 
In the present study, 11 of the 16 analyzed dialysis sites in Fig. 1 
showed breathing frequency responses to NMDA injection of 15% or 
more, suggesting that the MT was within the preBötC region.26,27 At 
five sites there was no or minimal response to NMDA injection and 
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histological assessment suggested that the MTs were outside the 
targeted preBötC region. Because the injection tube was inserted only 
up to the distal end of the MT, a lack of response to NMDA was likely 
due to an extended distance between the injection site and the 
preBötC. However, during dialysis, the membrane tip of the probe 
extends 2 mm beyond the distal end of the MT, thus the diffusion 
distance of dialyzed antagonists was likely not identical to that of 
injected NMDA. Nevertheless, in this and our previous studies,25–27 the 
concentration of neuromodulators (specifically, SP) in the effluent 
mCSF has been remarkably consistent, irrespective of the NMDA 
response and histological identification of MT placement. Thus we have 
not excluded data from goats in which there was no or minimal 
response to NMDA. Finally, due to variation in the NMDA response and 
histological identification of MT placement, we refer to observed effects 
within the VRC and not specifically to the preBötC. 
 
Fig. 10. Examples of an abnormal respiratory response to daytime dialysis of a triple 
cocktail of antagonists (5 mM ATR, 500 μM SPA, and 0.5 mM MDL). These animals 
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were not included in either the group means or statistical analyses. A: minute volume 
(VI, liters/min); B: frequency (F, breaths/min); C: tidal volume (VT, liters/breath). 
Diamonds (goat 12) and circles (goat 13) represent two different animals (see Fig. 1). 
The first data point represents the last 15-min bin of hour 1. Closed symbols and bar 
indicate period of cocktail dialysis; open symbols indicate mCSF dialysis. 
Blockade of 5-HT2A receptors in the VRC has modest 
effects on breathing and neuromodulator concentration.  
Comparisons between time-control studies (n = 7) and those of 
0.5 mM MDL dialysis (n = 6) found a modestly significant interaction 
effect only for VI (P = 0.046, Fig. 2A), and for which post hoc analysis 
indicated a significant difference (P < 0.05) between groups in the 
third bin of hour 2. There were no significant interaction effects for any 
other ventilatory parameter (≥0.160, Fig. 2, B and C). Dialysis of MDL 
did not significantly affect the effluent concentration of any 
neuromodulator measured (P ≥ 0.062, Fig. 3, A–E) relative to the 
time-control studies. 
 
Fig. 2. Dialysis of 0.5 mM of the antagonist MDL 11939 (MDL) (n = 6) in the ventral 
respiratory column (VRC) had no significant effect (P ≥ 0.160) on frequency (F, 
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breaths/min, B) or tidal volume (VT, liters/breath, C) relative to time-control studies (n 
= 7). However, MDL had a modestly significant effect on minute ventilation (VI, 
liters/min, P = 0.046, A). The first data point represents the last 15-min bin of hour 1. 
Closed symbols and bar indicate period of MDL dialysis; open symbols indicate mock 
cerebral spinal fluid (mCSF) dialysis. F and P indicate values for interaction term from 
two-way repeated-measures (RM) ANOVA. #P ≤ 0.05 between groups per post hoc 
analysis. 
 
Fig. 3. Dialysis of 0.5 mM MDL (n = 6) in the VRC had no significant effect (P ≥ 
0.062) on the effluent concentrations of serotonin (5-HT, A), glutamine (GLN, B), 
substance P (SP, C), glycine (D), or GABA (E) relative to time-control studies (n = 7). 
The x-axes indicate hour of dialysis; y-axes indicate effluent neurochemical 
concentration. Filled bars indicate dialysis of MDL; open bars indicate dialysis of mCSF. 
Bars on the left are data from time-control studies; bars on the right are data from 
MDL studies. F and P indicate values for interaction term from two-way RM ANOVA. 
Effects on breathing and neuromodulator concentration 
of blockade of mACh, NK1, and 5-HT2A receptors.  
Combined blockade of mACh receptors and NK1 receptors in the 
VRC via dialysis of a double cocktail of antagonists (5 mM ATR and 267 
μM SPA, n = 5) had no significant effect on any ventilatory parameter 
(P ≥ 0.084, Fig. 4, A–C) relative to the time-control studies. Double 
blockade of mACh receptors and NK1 receptors significantly increased 
the effluent concentration of SP (P < 0.001, Fig. 5C) when it was 
significantly elevated during hours 2 and 3 compared with both 
baseline and time-control values (P < 0.001) as determined by post 
hoc analysis. The double cocktail had no significant effect on the levels 
of any other neuromodulator (P ≥ 0.058; Fig. 5, A, B, D, and E). 
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Fig. 4. Dialysis of a double cocktail of antagonists [5 mM atropine (ATR), 267 μM 
Spantide I (SPA, an NK1 receptor antagonist), n = 5] in the VRC had no significant 
effect (P ≥ 0.084) on any respiratory parameter relative to time-control studies (n = 
7). A: minute ventilation (VI, liters/min); B: frequency (F, breaths/min); C: tidal 
volume (VT, liters/breath). The first data point represents the last 15-min bin of hour 
1. Closed symbols and bar indicate period of cocktail dialysis; open symbols indicate 
mCSF dialysis. F and P indicate values for interaction term from two-way repeated-
measures ANOVA. 
 
Fig. 5. Dialysis of a double cocktail of antagonists (5 mM ATR, 267 μM SPA, n = 5) in 
the VRC significantly increased the effluent SP concentration (P < 0.001, C) relative to 
time-control studies (n = 7) but had no significant effect (P > 0.05) on serotonin (5-
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HT, A), glutamine (GLN, B), glycine (D), or GABA (E), although the effect on GABA 
was close to significant. The x-axes indicate hour of dialysis; y-axes indicate effluent 
neurochemical concentration. Filled bars indicate dialysis of cocktail; open bars 
indicate dialysis of mCSF. Bars on the left are data from time-control studies; bars on 
the right are data from cocktail studies. F and P indicate values for interaction term 
from two-way RM ANOVA. **P ≤ 0.001 vs. hour 1; ††P ≤ 0.001 vs. hour 2; ##P ≤ 
0.001 vs. time-control value per post hoc analysis. 
Similarly, blockade of receptors of mACh, NK1, and 5-HT2A with 
a triple cocktail of antagonists (5 mM ATR, 500 μM SPA, and 0.5 mM 
MDL, n = 6) during the day had no significant effect on any respiratory 
variable (P ≥ 0.509, Fig. 6, A–C). However, there was a significant 
increase in effluent SP concentration (P < 0.001, Fig. 7C). As with the 
double cocktail, post hoc analysis showed that SP remained 
significantly elevated during hours 2 and 3 with triple cocktail dialysis 
compared with both baseline and time-control values (P ≤ 0.001). 
There were significant decreases in effluent glutamine (P = 0.010, Fig. 
7B) and GABA (P = 0.045, Fig. 7E) concentrations. Post hoc analysis 
indicated that glutamine decreased over time with triple cocktail 
dialysis (P ≤ 0.001) and was significantly different than time-control 
values in hour 3 (P < 0.05). Effluent GABA concentration also 
decreased over time (P ≤ 0.001) as revealed by post hoc testing, 
however, there was also a significant difference in baseline GABA 
concentration between the cocktail and time-control groups (P < 
0.05). Blockade with a triple cocktail did not significantly affect the 
effluent concentrations of 5-HT or glycine (P ≥ 0.136, Fig. 7, A and D). 
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Fig. 6. Daytime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA, 
and 0.5 mM MDL, n = 6) in the VRC had no significant effect (P ≥ 0.509) on any 
respiratory parameter relative to time-control studies (n = 7). A: minute ventilation 
(VI, liters/min); B: frequency (F, breaths/min); C: tidal volume (VT, liters/breath). The 
first data point represents the last 15-min bin of hour 1. Closed symbols and bar 
indicate period of cocktail dialysis; open symbols indicate mCSF dialysis. F and P 
indicate values for interaction term from two-way RM ANOVA. 
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Fig. 7. Daytime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA, 
and 0.5 mM MDL, n = 6) in the VRC significantly increased the effluent concentration 
of substance P (SP, P < 0.001, C) and significantly decreased (P ≤ 0.045) the effluent 
concentrations of glutamine (GLN, B) and GABA (E); cocktail dialysis had no significant 
effect (P ≥ 0.136) on serotonin (5-HT, A) or glycine (GLY, D) concentration. The x-
axes indicate hour of dialysis; y-axes indicate effluent neurochemical concentration. 
Filled bars indicate dialysis of cocktail; open bars indicate dialysis of mCSF. Bars on 
the left are data from time-control studies; bars on the right are data from cocktail 
studies. F and P indicate values for interaction term from two-way repeated-measures 
ANOVA. **P ≤ 0.001 vs. hour 1; ††P ≤ 0.001 vs. hour 2; #P < 0.05; ##P ≤ 0.001 vs. 
time-control value per post hoc analysis. 
Nighttime effects on breathing and neuromodulator 
concentration of blockade of mACh, NK1, and 5-HT2A 
receptors.  
Dialysis of the same triple cocktail of antagonists (5 mM ATR, 
500 μM SPA, and 0.5 mM MDL, n = 5 for ventilatory data, n = 6 for 
neurochemical data) at night had no state-dependent effects on any 
ventilatory variable (P ≥ 0.134, Fig. 8, A–C) as determined by the 
interaction term for sleep state and time from two-way RM ANOVAs. 
However, there were significant increases in effluent 5-HT (P = 0.040, 
Fig. 9A) and SP (P < 0.001, Fig. 9C) concentrations, although post hoc 
analysis of 5-HT data did not identify which hours were significantly 
different. SP was significantly elevated during hours 2 and 3 (P < 
0.001, post hoc). Triple-cocktail dialysis at night had no significant 
effect on the effluent concentration of any of the three amino acids (P 
≥ 0.210; Fig. 9, B, D, and E). 
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Fig. 8. Nighttime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA, 
and 0.5 mM MDL, n = 5) in the VRC did not have significant state-dependent effects 
on any respiratory parameter (P ≥ 0.134). A: minute ventilation (VI, liters/min); B: 
frequency (F, breaths/min); C: tidal volume (VT, liters/breath). Squares represent 
breathing during non-rapid eye movement sleep; circles represent breathing during 
wakefulness. The first data point represents the last 15-min bin of hour 1. Closed 
symbols and bar indicate period of cocktail dialysis; open symbols indicate mCSF 
dialysis. F and P indicate values for interaction term from two-way RM ANOVA. 
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Fig. 9. Nighttime dialysis of a triple cocktail of antagonists (5 mM ATR, 500 μM SPA, 
and 0.5 mM MDL, n = 6) in the VRC significantly increased the effluent concentrations 
of serotonin (5-HT, P = 0.040, A) and substance P (SP, P < 0.001, C) while having no 
significant effect (P ≥ 0.210) on glutamine (GLN, B), glycine (GLY, D), or GABA (E). 
The x-axes indicate hour of dialysis; y-axes indicate effluent neurochemical 
concentration. Filled bars indicate dialysis of cocktail; open bars indicate dialysis of 
mCSF. F and P indicate values from one-way RM ANOVA. **P ≤ 0.001 vs. hour 1; †P 
≤ 0.05 vs. hour 2 per post hoc analysis. 
Animals excluded from statistical analyses.  
In two additional animals, day (Fig. 10) and night (data not 
shown) dialysis studies of the same triple cocktail of antagonists were 
completed. These goats were not included in either the group means 
or statistical analyses because they had an abnormally strong 
response to the cocktail, characterized by a large, sustained increase 
in VI (Fig. 10A) driven by an increase in breathing frequency (Fig. 
10B). VT did not appear to be much affected by triple cocktail dialysis 
(Fig. 10C). 
Discussion 
No effect of combined receptor blockade on breathing.  
Many studies have previously demonstrated the contributions to 
breathing of muscarinic, NK1, and 5-HT receptors in various 
models.3,5,11,16,17,28,32,34,35,42,46 However, the large array of excitatory 
and inhibitory inputs to the respiratory network10 suggests that 
neuromodulators likely act in concert to regulate breathing. 
Furthermore, their effects might not necessarily be additive, and the 
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effects of one modulator may be dependent on the presence or 
absence of another modulator.9 The importance of understanding the 
effects of multiple receptor types on breathing has also been pointed 
out by Doi and Ramirez,10 who noted that “future studies need to 
address the combinatory effects of different neuromodulators. For 
example, by simultaneously blocking muscarinic, nicotinic, 5-HT2 and 
NK1 receptors. . . . to learn whether the contribution of each 
neuromodulator is cumulative and whether the drive of all 
neuromodulators is necessary for maintaining baseline frequency.” 
We hypothesized that simultaneous blockade of muscarinic, 
NK1, and 5-HT2A receptors would not alter breathing, but it would alter 
multiple neuromodulators. The hypothesis was confirmed, because we 
found that combined blockade of receptors of mACh, NK1, and 5-HT2A 
did not significantly affect breathing, but it consistently increased the 
effluent concentrations of SP while significantly decreasing or tending 
to decrease the effluent concentrations of GABA. 
We previously found that unilateral dialysis into the VRC of 50 
mM ATR increased 5-HT and SP in the effluent mCSF,25 which we 
postulate may have overcompensated for a reduction in muscarinic 
excitation to thereby increase breathing. In that study, the inhibitory 
neuromodulators GABA and glycine also increased, possibly in 
response to overcompensation in 5-HT and SP release. Importantly, 
these changes in neuromodulators occurred specifically at the site of 
dialysis, not in the contralateral VRC, indicating that neuromodulator 
interdependence likely occurs locally and not globally.25 In subsequent 
studies, including the present, we unilaterally dialyzed a lower 
concentration of ATR,26 and antagonists to NK127 and 5-HT2A receptors 
individually, and we also dialyzed these excitatory receptor antagonists 
simultaneously. Overall, none of these treatments altered breathing, 
but SP consistently increased, and GABA either tended to decrease in 
the dialysate, or it did so significantly. In the present study, the 
changes in SP and GABA may have compensated for the presumed 
reduction in neuronal excitation with blockade of 5-HT2A, NK1 and 
muscarinic receptors, resulting in no change in breathing. 
Although neuromodulator interdependence appears to be 
mediated locally, other potential contributing mechanisms to maintain 
stable breathing could be through anatomical connectivity with the 
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contralateral preBötC,41 or through reflex compensation independent of 
changes in neuromodulators in the contralateral preBötC. Indeed, we 
have shown that bilateral neurotoxic destruction of the preBötC in 
awake goats results in terminal apnea.47 However, unilateral 
destruction did not induce apnea, but it did induce hypoventilation for 
several hours. Additionally, St-Jacques and St-John38 found in 
decerebrate, vagotomized rats that attenuation of preBötC activity 
with unilateral injection of muscimol, the inhibitory GABA agonist, 
resulted in several minutes of respiratory apnea. Moreover, in 
anesthetized mice, unilateral injections into the preBötC of an 
excitatory receptor antagonist or a cocktail of antagonists caused a 
significant decrease in respiratory frequency.11 These examples of 
hypoventilation/apnea resulting from unilateral perturbations are in 
contrast to our findings that unilateral dialysis of antagonists to 
excitatory receptors appears to elicit a rapid and precise response to 
maintain stable breathing. Accordingly, our unilateral dialysis studies 
demonstrate an important fundamental characteristic of the 
respiratory control network: that is, its ability to compensate for 
fluctuations in excitatory input. Furthermore, neuromodulator 
interdependence does not appear to be unique to the preBötC region 
because we found changes in neuromodulators irrespective of the site 
of dialysis in the VRC (Fig. 1). Moreover, in previous studies, we found 
that dialysis of ATR into the pontine Kölliker-Fuse nucleus elicited 
increases in SP comparable to ATR dialysis into the VRC (unpublished 
data). Finally, we speculate that neuromodulator interdependence may 
not be unique to the respiratory control network nor even to 
mammals, because it likely occurs in other central-pattern generators 
such as those controlling mastication, locomotion, and the crustacean 
stomatogastric ganglion and cardiac ganglia, which generate motor 
patterns.4,9,23,31 
Potential mechanisms stabilizing breathing in the face 
of ubiquitous neuromodulation or attenuation of 
multiple neuromodulation.  
In a recent overview of neuromodulation of neuronal circuits, 
Dr. Eve Marder23 addressed two pertinent questions. First, why don't 
neural circuits important for behavior become overmodulated? And 
second, what mechanisms might protect against overmodulation? She 
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thereby proposed five potential stability mechanisms: 1) modulators 
that coordinately act on opposing processes by acting on both inward 
and outward currents; 2) voltage-dependence of modulator actions; 3) 
convergence of many modulators onto the same voltage-dependent 
current (or, as we additionally suggest, convergence onto the same 
second-messenger pathway); 4) saturation of postsynaptic action; and 
5) modulators act coordinately on multiple targets to keep systems 
functionally matched (i.e., coordinated modulation of the central 
pattern generator, the neuromuscular junction, and muscle activity).23 
One or more of these protective mechanisms against overmodulation 
may also be protective against the reverse situation of excessive 
attenuation of excitatory neuromodulator receptor activity due to 
antagonist dialysis. For example, receptors targeted by our antagonist 
cocktails couple to G protein-coupled receptors of the Gq/11 subtype,10 
thereby converging on the same second-messenger system, the 
phospholipase C (PLC) pathway. This commonality might explain why 
5 mM ATR,26 SPA,27 and MDL each had the same effect on breathing 
(i.e., no effect) when dialyzed individually or in combination. It is also 
possible that simultaneous blockade of mACh, NK1, and 5-HT2A 
receptors is still not enough to significantly depress activity in the PLC 
pathway to a degree such that breathing is affected. This may be due 
to the multitude of other receptors that couple to the Gq/11 subtype,10 
such as the α-1 adrenergic and P2Y purinergic receptors,10,13 both of 
which can modulate respiratory network activity.21,43 
Alternatively, potentiation of signaling in parallel pathways 
might partially account for the maintenance of breathing during 
antagonist challenge. The most consistent finding in these and past 
studies is an antagonist-induced increase in effluent SP 
concentration.25–27 It is possible that the excess SP may be binding and 
activating NK2 and NK3 receptors, negating the antagonist effects on 
NK1 receptors.6,33,39 NK2 and NK3 receptors have previously been 
shown to provide excitatory modulation in the rabbit preBötC, likely 
through activation by SP,2 which can also exert effects through these 
receptors.6 Another example is the 5-HT4A receptor, which is coupled 
to the Gs G protein-coupled receptor subtype. Activation of this 
receptor leads to stimulation of adenylyl cyclase, the protein kinase A 
pathway, and inactivation of potassium channels.10 The 5-HT4A 
receptor is known to be expressed in the preBötC and has excitatory 
respiratory effects capable of reversing fentanyl-induced respiratory 
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depression.22 Thus any 5-HT in the extracellular space, presumably 
blocked from interacting with 5-HT2A receptors during MDL or cocktail 
dialysis, may instead be acting on 5-HT4A receptors to stimulate 
breathing without any necessary increases in 5-HT concentration. In 
summary, the point we wish to emphasize is that there may be 
adequate redundancy and multiplicity of excitatory inputs to the VRC, 
such that blocking a subset of these receptors with double or triple 
cocktails of antagonists would be insufficient to significantly decrease 
breathing. 
Finally, the most consistent effect on neuromodulator 
concentration of cocktail dialysis was an increase in SP and a tendency 
for GABA to decrease, although the changes in GABA were not all 
significant. If NK1 receptors and 5-HT2A receptors are blocked, it is 
possible that the decrease in effluent GABA concentration may have 
offset reduced activation of excitatory receptors, preventing an 
attenuation of breathing with cocktail dialysis. Due to involvement of 
glutamine in the reuptake and recycling of GABA,1 the observed 
decreases in glutamine we report may reflect decreases in GABA 
release. 
Additional neuromodulatory inputs with the potential 
for compensation.  
It is important to note that neuromodulators not measured 
herein may have had effects that contributed to the maintenance of 
breathing observed in the present studies. These neuromodulators 
likely include orexin,8 histamine,10 ATP,13,15,21 prostaglandins,19 and 
catecholamines.43 Evidence from past work shows that the modulatory 
environment can reversibly affect the number and type of pacemaker 
cells in a population of respiratory neurons,43 and that physiological 
state (e.g., hypoxia) can influence the dependence of the respiratory 
network on different modulators/pacemaker currents. Examples of 
modulators that illustrate these points are norepinephrine (NE) and 5-
HT. In mouse brainstem slices containing the ventral respiratory 
group,43 application of NE was found to increase fictive respiratory 
frequency via the α-1 receptor. In addition to differentially modulating 
burst shape and frequency of distinct pacemaker neurons, NE also 
induced conditional expression of cadmium-sensitive pacemaker 
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properties in what were originally nonpacemaker neurons.43 
Conversely, pacemaker properties of cadmium-insensitive neurons are 
instead dependent on 5-HT2A receptors.30 Whereas bursting in 
cadmium-sensitive pacemakers is dependent on the nonspecific cation 
current (ICAN), bursting properties in cadmium-insensitive pacemakers 
depend on the persistent sodium current (INaP).14,29,45 Finally, during 
hypoxia and subsequent gasping behavior, the respiratory network is 
believed to reconfigure into one that is selectively dependent on 
INaP.10,12,14,29 Thus subtle changes in (or complete blockade of) NE or 5-
HT may have altered the relative expression of these current types or 
the dependence of the respiratory network on a given 
modulator/current type. Reconfiguration of the network in this manner 
during antagonist dialysis may partially account for the stability of 
breathing. 
A neuromodulator may also have different effects on breathing 
depending on the modulatory/physiological state of the network, as 
previously proposed by others.11 This concept has been recently 
demonstrated by Zanella et al.49 In those studies, NE, which can act to 
stabilize respiratory activity in reduced preparations,44 was found to 
actually increase respiratory irregularity in vitro and in vivo, 
specifically after exposure to acute intermittent hypoxia.49 Similarly, 
prostaglandin E2 (PGE2) when applied at low concentrations has been 
shown by Koch et al.19 to selectively increase sigh frequency, but not 
eupneic frequency, although it increases both sigh and eupneic 
frequency at higher concentrations. Using inhibitors of the INaP and 
ICAN, the study further suggests that the contrasting effects of PGE2 
concentration on distinct respiratory behaviors may be due to 
differential modulation of INaP at low concentrations vs. ICAN at higher 
concentrations. Thus the effect of a modulator is context-dependent, 
and changes in the balance of excitatory and inhibitory modulators 
may drastically alter the net output of a network. This phenomenon 
has been previously demonstrated in other neural networks; 
specifically, the cardiac sac motor pattern in the lobster, wherein the 
effect of proctolin is dependent upon exposure of the network to red-
pigment-concentrating hormone.9 
Relevant to the preceding discussion on modulatory 
environment are findings on two goats that displayed large, sustained 
increases in breathing frequency (+20 breaths/min) with dialysis of 
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the triple cocktail of antagonists, both in the day (Fig. 10) and night 
(data not shown), while awake and in NREM sleep. The responses of 
these animals were clearly different from those of the rest of the 
group; as such, they were excluded from group means and statistical 
analysis. An interesting distinguishing feature common to these two 
goats was a higher-than-average baseline breathing frequency (≥30 
breaths/min). Daytime baseline levels of 5-HT and SP were within 
normal range and changes in these neuromodulators with dialysis of 
the triple cocktail were comparable to those of the rest of the group. 
However, one animal had lower-than-average baseline levels of glycine 
and GABA, which may have partially contributed to an overall higher 
baseline breathing frequency. Although it is difficult to determine the 
precise cause of the elevated baseline breathing, these observations 
suggest that the response to receptor blockade may be dependent 
upon the initial modulatory or physiological state of the animal. 
Indeed, the dependence of a drug effect on baseline respiratory 
activity has been demonstrated in other studies. In particular, studies 
in anesthetized mice found that hemilateral injection of a NK1 receptor 
antagonist (RP67580) into the preBötC region significantly decreased 
respiratory frequency.11 However, the inhibitory effect of RP67580 was 
significantly correlated with the baseline breathing frequency of the 
animal: mice with lower starting frequencies showed a larger decrease 
in frequency with NK1 receptor blockade.11 The same studies found 
that when both α-1 NE and 5-HT2 receptors were blocked, the 
inhibitory effect of RP67580 was further accentuated. The authors 
therefore concluded that breathing depends on NK1 receptor activation 
more so at low breathing frequencies or under conditions of reduced 
excitatory transmission. The contrasting effects of receptor blockade 
on breathing in these mouse studies (decrease) vs. our observations in 
goats (increase) may be due to the use of anesthesia. Despite this 
caveat, both models suggest that the effect of an antagonist on 
breathing may depend on the respiratory/modulatory state of the 
animal. 
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Limitations.  
Technical limitations and sample availability prevented 
measurement of ACh/choline and thyrotropin-releasing hormone in the 
present studies. The limitations of the use of dialysis in our animal 
model to investigate the control of breathing have been discussed in 
greater detail in previous publications;25,26 only a brief summary is 
given here. First, the precise boundaries of the goat preBötC remain 
unclear,20 rendering MT placement difficult in some animals. Second, 
determination of the diffusion area of dialyzed substances can be 
problematic. Accordingly, we cannot precisely identify the site affected 
by NMDA injections or dialysis of antagonists, thus we believe it most 
appropriate to state that our observed effects were within the VRC. 
Third, the length of the infusion line connecting the syringe in the 
dialysis pump to the probe (i.e., dead space in delivery) required ∼20 
min for fresh solution to reach the probe, thus antagonist delivery 
continued for 20 min into the third hour of mCSF dialysis. This dead 
space in our delivery system likely explains why SP consistently 
remained elevated during hour 3. Fourth, pertinent to our night 
studies, we were unable to separate neurochemicals collected during 
different sleep states. Additionally, sleep state-associated changes in 
fractional interstitial volume48 have been previously reported, which 
would affect both modulator and drug concentrations in the tissue. 
Finally, repeated probe insertions in one MT may have caused potential 
tissue damage around the site of dialysis. 
Conclusion.  
Combined unilateral blockade of mACh, NK1, and 5-HT2A 
receptors in the goat VRC does not affect breathing. This lack of effect 
may be due to a number of compensatory mechanisms, including 
redundancy/multiplicity of excitatory inputs to the VRC, activation of 
parallel signaling pathways, the contribution of other neuromodulators 
not measured herein, the effects of changes in the modulatory milieu 
on the number and type of pacemakers in the VRC, or alterations in 
the dependence of the respiratory network on different 
modulators/current types. Our data suggest that many interacting 
systems may need to be substantially impaired for the emergence or 
complete manifestation of respiratory deficits. If such is the case, it 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Applied Physiology, Vol 119, No. 3 (August 1, 2015): pg. 308-320. DOI. This article is © American Physiological 
Society and permission has been granted for this version to appear in e-Publications@Marquette. American Physiological 
Society does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from American Physiological Society. 
28 
 
would be highly relevant to disease conditions in which multiple 
modulator systems are affected. An example of such is Rett syndrome, 
in which abnormalities in glutamate, GABA, brain-derived neurotrophic 
factor, NE, and 5-HT have all been implicated in the respiratory 
pathologies associated with the disorder.18 Our conclusions emphasize 
the need to adopt a multiform approach in treating such conditions or 
alleviating associated respiratory defects. Furthermore, anecdotal 
evidence and the published work of others11 suggest that the 
effectiveness of a treatment may be dependent on the initial 
respiratory status of the patient. 
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